🔴 Gain Therapeutics is trading 10% down amid biotech-sector weakness

Gain Therapeutics is trading at $1.41, down 10.18%, with no confirmed company-specific catalyst identified.

• The supplied market context reports XBI down 2.01% during the regular session.
• No company announcement dated October 13, 2026, was found; the latest newsroom item listed was dated October 8.
• The sector decline offers context but does not establish the cause of Gain Therapeutics’ larger drop.